MOKINGRAN (02585): The Stock Exchange of Hong Kong approves the listing of all H shares for full circulation.

21:24 02/02/2026

Meng Jinyuan (02585) announced that the company has received approval from the Hong Kong Stock Exchange on January 30, 2026 for the listing and trading of 40 million H shares of the company (converted H shares, i.e. the total number of unlisted shares to be converted and listed).

MOKINGRAN (02585) issued an announcement that the company has received approval from the Hong Kong Stock Exchange on January 30, 2026 for the listing and trading of 40 million H shares (converted H shares, i.e. the total number of non-listed shares to be converted according to the conversion and listing) granted by the Stock Exchange.

Pagoda GP (02411) diluted its equity stake in Bai Guoyuan Commercial Management to 51.02%. The core management team increased its investment to expand into new business areas.

Tianli International Holdings (01773) director Luo Shi acquired an additional 1 million shares.

CHINA HEALTH (00673) issued a total of 40.638 million share options.

Pagoda GP (02411) diluted its equity stake in Bai Guoyuan Commercial Management to 51.02%. The core management team increased its investment to expand into new business areas.

Tianli International Holdings (01773) director Luo Shi acquired an additional 1 million shares.

CHINA HEALTH (00673) issued a total of 40.638 million share options.